Skip Navigation
  • Careers
  • Report a Claim
  • Clients
  • Contact Us
  • Employees
Risk Strategies Logo
  • Industries

    • Architects & Engineers
    • Aviation
    • Cannabis
    • Construction
    • Education
    • Entertainment
    • Financial Services
    • Fine Art
    • Healthcare
    • Law Firms
    • Marine & Yacht
    • Nonprofit & Human Services
    • Private Equity
    • Public Sector
    • Real Estate
    • Relocation
    • Transportation
    • Waste & Recycling
  • Solutions

      • Captives
      • Casualty
      • Cyber
      • Environmental
      • International Liability
      • Management Liability
      • Property
      • Surety
      • Employee Benefits Overview
      • Benefit Administration and Technology
      • Benefits Compliance Support
      • Data & Analytics
      • Human Capital Management
      • International Benefits
      • Absence Management & Ancillary Programs
      • Voluntary & Lifestyle Benefits
      • Financial & Wealth Overview
      • Life Insurance
      • Private Client Services Overview
      • Homeowners
      • Collections
      • Umbrella & Excess Liability
      • Auto
      • Boat & Yacht
      • Family Office
      • Specialty Coverages
    • Reinsurance
      • Risk Management Services Overview
      • Analytics
      • Claims Management & Advocacy
      • Loss Control
      • Safety Consulting Services
  • Consulting

    • Consulting Overview
    • Actuarial Services
    • Healthcare Claim Audit Services
    • Health and Welfare
    • Mergers and Acquisitions
    • Pharmacy
    • Retirement Benefits
  • News and Insights

    • All Insights
    • Blog
    • Emergency Resource Centers
    • Employee Benefits Compliance Center
    • Events
    • Media Coverage
    • State of the Market Reports
    • Press Releases
  • Company

    • About Us
    • Careers
    • Culture and Values
    • Diversity, Equity & Inclusion
    • Environmental, Social, & Governance
    • General Terms of Business
    • Leaders
    • Local Expertise
    • Mergers & Acquisitions
    • Recognition & Awards
    • Risk Strategies Charitable Foundation
    • Transparency and Disclosures
  • Join Us
    • Careers
    • Mergers & Acquisitions
  • Industries
    • Architects & Engineers
    • Aviation
      • Aviation Business Insurance - Manned Risk
      • Non-Owned Aviation
      • Unmanned Aerial System and Drones
    • Cannabis
    • Construction
      • Alternative Solutions
      • Financing & Pre-Construction
      • Insurance Solutions
      • Risk Management
      • Surety
    • Education
      • Employee Benefits for Education
      • Property, Casualty & Liability for Education
      • Student Health & Wellness
    • Entertainment
      • Film & Television
      • Advertising Wrap-Ups
      • Event Cancellation & Non-Appearance
      • Music & Touring
      • Theatrical Production & Live Performance 
    • Financial Services
      • Asset Managers
      • Banks & Non-Bank Lending
      • Collections
      • Consumer Financial Services
      • Financial Tech
      • Insurance Companies
    • Fine Art
      • Artists
      • Artist Endowed Foundations
      • Auction Houses
      • Fine Art Packers / Shippers / Warehouses
      • Galleries
      • Museums
      • Private Art Dealers / Advisors
      • Private Collectors
    • Healthcare
      • Employee Benefits - Healthcare
      • Managed Care / Stop Loss
      • Medical Malpractice
      • Property & Casualty - Healthcare
      • Reinsurance
    • Law Firms
    • Marine & Yacht
      • Boat & Yacht For Individuals
      • Classic Yachts
      • Commercial & Recreational Marine Businesses
        • Marine Businesses
        • Sailing Organizations - Burgee Program
      • High Performance Boats
      • Jackline Program for Cruising Yachts
      • Mega Yachts
      • One-Design Insurance Program
      • Sailors Health Insurance Program
      • Travel Medical & Trip Insurance
      • US Sailing Insurance Solutions
    • Nonprofit & Human Services
    • Private Equity
    • Public Sector
      • Public Safety Organizations & Municipalities
    • Real Estate
      • Commercial
      • Community Associations
      • Hospitality
      • Residential / Habitational
      • REITs
      • Retail
      • Specialty Programs
    • Relocation
      • Domestic Household Goods
      • Expat Renters & Living Insurance
      • Relocation Claims Service
      • International Household Goods
      • Supplemental Movers Coverage
      • Temporary Living Insurance
      • Vacant Home
    • Transportation
      • Business Auto Insurance
      • Last Mile Delivery
      • Forwarding & Brokering
      • Workers' Compensation
    • Waste & Recycling
  • Solutions
    • Business Insurance
      • Captives
      • Casualty
        • Analytics
        • Auto Liability & Physical Damage
        • Captives & Alternative Risk Financing
        • Claims Advocacy & Loss Control
        • Excess Liability
        • General Liability
        • Product Recall
        • Workers' Compensation
      • Cyber
        • Cyber Resolute
        • Cyber Risk Assessment and Analytics
        • Cyber Risk Response & Claims Advocacy
      • Environmental
        • Contractors Pollution Liability
        • Environmental Excess
        • Environmental Liability Transfer
        • Environmental Liability - Healthcare
        • Environmental Liability - Higher Education
        • Pollution Legal Liability
        • Environmental Liability - Private Equity
        • Professional Environmental Liability Insurance
        • Real Estate Development
        • Remediation Cost Cap
        • Secured Creditor Protection for Lenders
        • Underground Storage Tanks
      • International Liability
      • Management Liability
        • Management Liability - Entertainment
        • Management Liability - Financial Institutions
        • Management Liability - Healthcare
        • Management Liability - Real Estate
      • Property
        • Builder's Risk
        • Property Claims Services
        • Inland Transit and Ocean Cargo
        • Natural Hazard Catastrophe Modeling
        • Political Violence and Terrorism
        • Property Damage & Business Interruptions Valuations
        • Property Loss Prevention and Control
      • Surety
    • Employee Benefits
      • Employee Benefits Overview
      • Benefit Administration and Technology
      • Benefits Compliance Support
      • Data & Analytics
      • Human Capital Management
      • International Benefits
      • Absence Management & Ancillary Programs
      • Voluntary & Lifestyle Benefits
    • Financial & Wealth
      • Financial & Wealth Overview
      • Life Insurance
    • Private Client Services
      • Private Client Services Overview
      • Homeowners
      • Collections
      • Umbrella & Excess Liability
      • Auto
      • Boat & Yacht
      • Family Office
      • Specialty Coverages
    • Reinsurance
    • Risk Management Services
      • Risk Management Services Overview
      • Analytics
      • Claims Management & Advocacy
      • Loss Control
      • Safety Consulting Services
  • Consulting
    • Consulting Overview
    • Actuarial Services
    • Healthcare Claim Audit Services
    • Health and Welfare
    • Mergers and Acquisitions
    • Pharmacy
    • Retirement Benefits
  • News and Insights
    • All Insights
    • Blog
    • Emergency Resource Centers
      • Cybersecurity
      • Earthquake
      • Hurricane
      • Pandemic
      • Riot & Civil Unrest
      • Severe Storms
      • Violence & Active Shooter
      • Wildfire
      • Winter Weather
    • Employee Benefits Compliance Center
    • Events
    • Media Coverage
    • State of the Market Reports
    • Press Releases
  • Company
    • About Us
    • Careers
    • Culture and Values
    • Diversity, Equity & Inclusion
      • BeHEARD Series
      • DE&I Structure
      • Employee Resource Groups
    • Environmental, Social, & Governance
    • General Terms of Business
    • Leaders
    • Local Expertise
    • Mergers & Acquisitions
    • Recognition & Awards
    • Risk Strategies Charitable Foundation
    • Transparency and Disclosures
      • General Terms of Business
      • Conflict of Interest Policy
      • Compensation Disclosure
      • Enterprise Risk Management
  • Join Us
    • Careers
      • Benefits & Wellness
      • Investing in Growth & Leadership
      • Life at Risk Strategies
      • Next Steps
    • Mergers & Acquisitions
      • Partnership Benefits
      • Why Join Us?
      • Onboarding & Integration
  • Careers
  • Report a Claim
  • Clients
  • Contact Us
  • Employees

You are about to leave Risk Strategies website and view the content of an external website.

You are leaving risk-strategies.com

By accessing this link, you will be leaving Risk Strategies website and entering a website hosted by another party. Please be advised that you will no longer be subject to, or under the protection of, the privacy and security policies of Risk Strategies website. We encourage you to read and evaluate the privacy and security policies of the site you are entering, which may be different than those of Risk Strategies.

OK
  • News & Insights
  • Blog
January 10, 2023

Biosimilars Poised to Deliver Savings to Pharmacy Benefits

Pharmacy Consulting Practice
4 min read
Risk Strategies Consulting, Pharmacy Consulting Services
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Biosimilars Poised to Deliver Savings to Pharmacy Benefits

Overview

One of the biggest challenges facing plan sponsors today is managing the growth of specialty drug spend. Specialty drugs are high-cost prescription medications that treat complex or rare conditions such as rheumatoid arthritis, multiple sclerosis, hemophilia, and cancer. According to Asembia's 2022 Summit Specialty Pharmacy Industry Update specialty drug spend now makes up over 50% of total pharmacy spend. Given the strong pipeline of new specialty medications anticipated in the coming years, we expect specialty drug spend will continue to increase. However, some relief is in sight as a result of upcoming launches of biosimilar products.

The U.S. government passed the Biologics Price Competition and Innovation Act in 2010 which created the first pathway for biosimilar approvals. At that time industry experts expected biosimilars to serve as a long-term specialty drug cost mitigation solution. After over a decade, this expectation may in fact come to fruition. The use of biosimilars can expand options, enhance affordability, and even increase access to therapies. According to IPD Analytics’ Biosimilar Pipeline Report, biosimilars are projected to produce $100 billion in savings for the U.S. health care system over the next five years.

2023 is expected to be a breakthrough year in the pharmaceutical industry with the anticipated launch of one or more biosimilars for several of the most commonly prescribed specialty drugs on the market. For example, Humira® has been the top-selling drug in the United States for years and will see competition for the first time in 2023 following a patent settlement. A total of eight FDA-approved Humira® biosimilars are already cleared for a 2023 release in the U.S. with the majority of the launches expected in July of 2023. These events will mark the most significant loss of exclusivity in the history of pharmaceuticals.

What are Biosimilars?

A biosimilar drug is designed very much like a reference (i.e., originator) drug that has already been approved by the Food and Drug Administration (FDA). Specialty drugs are often biologics, drugs composed of complex molecular structures that are derived from living organisms. Unlike molecular comparisons of brand and generic drugs, the complex structure of a biological drug limits the ability of a manufacturer to produce an exact copy of the molecule. Clinical trials must demonstrate a biosimilar drug is as effective and as safe as the originator drug in order to gain FDA approval.

Expanding Availability and Possibility

While biosimilars hold great promise to mitigate specialty drug costs, the marketplace for them has been confusing and unclear. To date, the embrace of biosimilars has been slower than expected. A few key factors are anticipated to increase biosimilar uptake for launches in the coming years:

  • Specialty drug benefit coverage. Past biosimilar launches have primarily been for clinician-administered drugs which are typically covered under the medical benefit where it is more difficult to influence prescribing. The upcoming launches include self-administered drugs that are covered under pharmacy benefit plans which allow for Pharmacy Benefit Managers (PBMs) to drive utilization to lowest net-cost products through effective formulary management strategies.
  • Biosimilar interchangeability status. Interchangeability status will significantly influence the uptake of biosimilars coming to market. The interchangeability status allows the dispensing pharmacist to substitute a biosimilar for a brand reference product – much like generics are substituted for brand drugs. Most biosimilars on the market today do not have interchangeability status. More manufacturers are seeking interchangeable status from the FDA for this reason.

Creating Significant Savings

After a slow start, the era of biosimilars has finally arrived, creating an opportunity for savings and improved patient affordability that will significantly improve the PBMs outlook in the years ahead. Attention should be focused on how these savings are transferred from the PBMs and medical carriers to their plan sponsors and associated members.

Learn more about Risk Strategies Pharmacy Consulting here.

The contents of this article are for general informational purposes only and Risk Strategies Company makes no representation or warranty of any kind, express or implied, regarding the accuracy or completeness of any information contained herein. Any recommendations contained herein are intended to provide insight based on currently available information for consideration and should be vetted against applicable legal and business needs before application to a specific client. 

Related Posts

See all posts

Private Equity 3 min read M&A: The need for speed matched wit... March 16, 2018
Private Equity Expanding Pursuits in Health Care Investment
Healthcare 5 min read Private Equity Expanding Pursuits i... April 08, 2022

Subscribe via Email

Risk Strategies Logo
  • Report a Claim
  • Clients
  • Contact
  • Employees
  • Terms of Use
  • Cookie Policy
  • Privacy Policy
  • Accessibility
  • Health Plan Transparency Compliance
©2023 Risk Strategies. All rights reserved.

Connect with Us

  • LinkedIn
  • Twitter
  • Instagram
  • Facebook